Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

A recent leak reveals Anthropic has completed training on Mythos 6, a powerful new AI model facing strict government scrutiny ...

Drug discovery has long been a slow, expensive process of trial and error, and for a small clinical-stage company, every wasted experiment is capital it can scarcely afford. That is the backdrop for a ...

Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

Improving email authentication is essential for organizations striving to maintain trusted communication and safeguard ...

AI educator and founder of The Cutting Edge Group, Ansh Mehra lauded Anthropic's initiative and said tech companies should agree to a self-imposed global pause on LLM (large language model) releases ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...